A Multicenter, Open-Label Study of Velaglucerase Alfa Enzyme Replacement Therapy in Japanese Patients With Gaucher Disease
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Velaglucerase alfa (Primary)
- Indications Gaucher's disease type I
- Focus Adverse reactions; Registrational
- Sponsors Shire
- 24 Oct 2013 New trial record